PMA device
MANTA Vascular Closure Device
Teleflex Medical, LLC · Device, Hemostasis, Vascular (MGB, Class III) · First FDA decision Feb 1, 2019, newest Jun 7, 2024Vascular access
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
10
Naming "MANTA"
MAUDE reports
1,660
Brand "MANTA", since 2015
PubMed studies
619
Mentioning "MANTA"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing MANTA Vascular Closure Device
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- MANTA Vascular Closure Device, 14F, MANTA Vascular Closure Device, 18F, MANTA 8F Depth Locator, MANTA 14F Depth LocatorPMA supplement
P180025-S012 · Decided Jun 7, 2024 · 63 days after receipt · Normal 180 Day Track No User Fee
Device type: Device, hemostasis, vascular (MGB) · Cardiology
- MANTA Vascular Closure Device, 14F, MANTA Vascular Closure Device, 18F, MANTA 8F Depth Locator, MANTA 14F Depth LocatorPMA supplement
P180025-S010 · Decided Oct 11, 2023 · 271 days after receipt · Normal 180 Day Track No User Fee
Device type: Device, hemostasis, vascular (MGB) · Cardiology
- MANTA Vascular Closure DevicePMA supplement
P180025-S009 · Decided Apr 19, 2021 · 68 days after receipt · Normal 180 Day Track
Device type: Device, hemostasis, vascular (MGB) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "MANTA", any status and sponsor, newest update first.
Essential Medical, Inc.Not on our public-company list
NCT05936996 · 258 participants · Start Nov 15, 2023 · Primary completion Jun 20, 2025
Device: MANTA Vascular Closure Device · For: Femoral Arteriotomy Closure
Sites: Jacksonville, Florida; Orlando, Florida; Detroit, Michigan · 10 sites in all
- MANTA Ultrasound Closure StudyTerminated
Essential Medical, Inc.Not on our public-company list
NCT05142566 · 17 participants · Start Aug 9, 2022 · Primary completion Jan 11, 2023
Device: MANTA Vascular Closure Device · For: Femoral Arteriotomy Closure
Sites: Washington D.C., District of Columbia; Detroit, Michigan; Buffalo, New York · 6 sites in all
RWTH Aachen UniversityAcademic, hospital or other
NCT05662748 · 250 participants · Start Jan 20, 2020 · Primary completion Mar 30, 2021
Device: Transfemoral aortic valve replacement · For: Aortic Valve Stenosis
Sites: Aachen, Germany
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "MANTA", and for the whole product code for context.
This brand
1,660 reports: 647 malfunction, 986 injury, 25 death
Whole product code MGB
93,533 reports: 17,154 malfunction, 76,023 injury, 315 death
Newest reports for this brand
3003898360-2026-00463 · Received Oct 27, 2026 · Event dated Sep 24, 2026
Device type: Device, Hemostasis, Vascular (MGB)
Device problem as coded: Failure to Seal
Patient problem as coded: Hemorrhage/Blood Loss/Bleeding; Obstruction/Occlusion; No Clinical Signs, Symptoms or Conditions
- Manta Vascular Closure Device 14FMalfunction
3003898360-2026-00451 · Received Oct 20, 2026 · Event dated Sep 22, 2026
Device type: Device, Hemostasis, Vascular (MGB)
Device problem as coded: Misconnection; Deformation Due to Compressive Stress; Physical Resistance/Sticking
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3003898360-2026-00449 · Received Oct 15, 2026 · Event dated Sep 16, 2026
Device type: Device, Hemostasis, Vascular (MGB)
Device problem as coded: Patient-Device Incompatibility; Failure to Seal
Patient problem as coded: Obstruction/Occlusion; Vascular Dissection
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "MANTA"[tiab]. The summary above synthesizes these.
- MANTA Dedicated Large-Bore Vessel Closure Device.
Tarantini G · Circ Cardiovasc Interv · 2019Editorial, Comment
- Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications.
Chen X, Schulz-Trieglaff O, Shaw R, et al. · Bioinformatics · 2016
- Evaluation of the MANTA Vascular Closure Device in Transfemoral TAVI.
Kmiec L, Zerdzitzki M, Schmid C, et al. · Thorac Cardiovasc Surg · 2023
- Complications of the MANTA Closure Device: Insights From MAUDE Database.
Megaly M, Sedhom R, Abdelmaseeh P, et al. · Cardiovasc Revasc Med · 2022
- MANTA versus Perclose for large-bore vessel closure: The evidence continues to grow.
Postalian A, Krajcer Z · Catheter Cardiovasc Interv · 2021Editorial, Comment
- Opportunistic sightings of manta rays on Brazil's Amazon Coast.
Bucair N, Dias HN, Nunes AROP, et al. · J Fish Biol · 2024
- Manual compression versus MANTA device for access management after impella removal on the ICU.
Cuculi F, Burkart P, Cioffi G, et al. · Sci Rep · 2022Research Support, Non-U.S. Gov't
- On MANTA vascular closure devices following veno arterial extracorporeal membrane oxygenation: Effectiveness and complications.
Berezin AE · World J Cardiol · 2025Editorial
- Manta-like planktivorous sharks in Late Cretaceous oceans.
Vullo R, Frey E, Ifrim C, et al. · Science · 2021Research Support, Non-U.S. Gov't
- Failed Manta Closure Device After High-Risk PCI.
Alrayes H, Kabbani L, Basir M · J Invasive Cardiol · 2022
- Totally endoscopic micro-invasive aortic valve replacement.
Bakhtiary F, Salamate S, Ahmad AE · Multimed Man Cardiothorac Surg · 2024Video-Audio Media
- The distribution of manta rays in the western North Atlantic Ocean off the eastern United States.
Farmer NA, Garrison LP, Horn C, et al. · Sci Rep · 2022Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code MGB.
- Angio-Seal Vascular Closure DeviceTerumo Medical Corporation · PMA 2013
- Perclose ProGlide® Suture-Mediated Closure SystemAbbott Vascular, Inc. · PMA 2025
- StarClose SE® Vascular Surgical SystemAbbott Vascular Devices · PMA 2025
- Mynx Vascular Closure DeviceCordis US Corporation · PMA 2013
- Vascade Vascular Closure System (VCS)Cardiva Medical, Inc. · PMA 2023
- MynxGrip and Mynx Ace Vascular Closure DeviceCordis US Corporation · PMA 2018
- Vascular Solutions Duett Sealing DeviceVascular Solutions, Inc. · PMA 2010
- Angio-Seal Hemostatic Puncture Closure DeviceTerumo Medical Corporation · PMA 2000
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.